Indivior Pharmaceuticals, Inc (INDV) insider trading
Every open-market stock purchase and sale by Indivior Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Woodrow D Anderson (C-suite exec) bought $108K in the last 90 days, growing their stake 6%.
- Christian Heidbreder (C-suite exec) sold $765K in the last 90 days.
Last 12 months: insiders bought $312K (10 buys) and sold $2.8M (3 sales). Last close $35.30 on Aug 27, 2026.
Recent INDV insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 27, 2026 | Woodrow D Anderson (C-suite exec) | Bought | $53.5K |
| Aug 5, 2026 | Woodrow D Anderson (C-suite exec) | Bought | $54.4K |
| Jul 10, 2026 | Christian Heidbreder (C-suite exec) | Sold | $765K |
| Jun 22, 2026 | Joseph Ciaffoni (CEO) | Sold (not open market) | $23.5M |
| Jun 22, 2026 | Joseph Ciaffoni (CEO) | Bought (not open market) | — |
| Jun 11, 2026 | Christian Heidbreder (C-suite exec) | Sold | $707K |
| Jun 8, 2026 | Ryan Preblick (CFO) | Sold | $1.4M |
| May 13, 2026 | Stuart A Kingsley (Director) | Bought (not open market) | — |
| May 13, 2026 | Juliet Thompson (Director) | Bought (not open market) | — |
| May 13, 2026 | Barbara Ryan (Director) | Bought (not open market) | — |
| May 13, 2026 | Daniel A Ninivaggi (Director) | Bought (not open market) | — |
| May 13, 2026 | David E. Wheadon (Director) | Bought (not open market) | — |
| May 13, 2026 | Keith Humphreys (Director) | Bought (not open market) | — |
| May 13, 2026 | Mark Stejbach (Director) | Bought (not open market) | — |
| May 12, 2026 | Juliet Thompson (Director) | Sold (not open market) | $42.8K |
| Mar 14, 2026 | Ryan Preblick (CFO) | Sold (not open market) | $88.4K |
| Mar 14, 2026 | Ryan Preblick (CFO) | Bought (not open market) | — |
| Mar 13, 2026 | Barbara Ryan (Director) | Bought | $249 |
| Mar 9, 2026 | Barbara Ryan (Director) | Bought | $1K |
| Mar 6, 2026 | Stuart A Kingsley (Director) | Bought | $30K |
| Mar 3, 2026 | Ryan Preblick (CFO) | Sold (not open market) | $2.8M |
| Mar 3, 2026 | Christian Heidbreder (C-suite exec) | Sold (not open market) | $1.5M |
| Mar 3, 2026 | Jeffrey W Burris (C-suite exec) | Sold (not open market) | $1.2M |
| Mar 3, 2026 | Woodrow D Anderson (C-suite exec) | Sold (not open market) | $265K |
| Mar 3, 2026 | Woodrow D Anderson (C-suite exec) | Sold (not open market) | $85.8K |
Who's trading INDV
- Woodrow D Anderson, C-suite exec: bought $108K (2 buys), last Aug 27, 2026
- Christian Heidbreder, C-suite exec: sold $1.5M (2 sales), last Jul 10, 2026
- Joseph Ciaffoni, CEO: other filings, last Jun 22, 2026
- Ryan Preblick, CFO: sold $1.4M (1 sale), last Jun 8, 2026
- David E. Wheadon, Director: bought $62.7K (1 buy), last May 13, 2026
- Keith Humphreys, Director: bought $27.4K (1 buy), last May 13, 2026
- Stuart A Kingsley, Director: bought $30K (1 buy), last May 13, 2026
- Daniel A Ninivaggi, Director: bought $27.4K (1 buy), last May 13, 2026
- Mark Stejbach, Director: bought $27.4K (1 buy), last May 13, 2026
- Juliet Thompson, Director: other filings, last May 13, 2026
- Barbara Ryan, Director: bought $28.7K (3 buys), last May 13, 2026
- Jeffrey W Burris, C-suite exec: other filings, last Mar 3, 2026
- Patrick A Barry, C-suite exec: other filings, last Feb 10, 2026
Get free alerts when an insider at Indivior Pharmaceuticals, Inc files a new trade →